Interest of circulating ICAM-1 plasma levels: From physiology to clinical applications;Interet des variations plasmatiques d'ICAM-1 soluble. De la physiologie a l'application clinique

Journal des Maladies Vasculaires

Volumn 25, Issue 3, 2000, Pages 156-165

  Gomez Scotto, E ^a   Seigneur, M ^a   Renard, M ^a   Houbouyan Reveillard, L L ^a   Boisseau, M R ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Endothelium; ICAM 1s; Inflammation

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; INTEGRIN RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ASSAY; CANCER; CELL CULTURE; CELL MEMBRANE; CEREBROSPINAL FLUID; ENDOTHELIUM; IMMUNOPATHOLOGY; INFLAMMATION; LEUKOCYTE ADHERENCE; LUNG LAVAGE; PROTEIN DEGRADATION; REVIEW; SERUM; SUPERNATANT; BLOOD; CELL ADHESION; GENERAL ASPECTS OF DISEASE; HUMAN; LEUKOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; VASCULAR ENDOTHELIUM;

CELL ADHESION; DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; REFERENCE VALUES;

EID: 0033912326     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. ADAMS DH, SHAW S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet, 1994 ; 343 : 831-6.
2. BARNETT CC, MOORE EE, MOORE FA, BIFFL WL, PARTRICK DA. Soluble intercellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD18. Surgery, 1996 ; 120 : 395-402.
3. BARNETT CC, MOORE EE, MOORE FA, CARL VS, BIFFL WL. Soluble ICAM-1 (sICAM-1) provokes PMN elastase release. J Surg. Res, 1996 ; 63 : 6-10.
4. BECKER JC, DUMMER R, HARTMANN AA, BURG G, SCHMIDT RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and TNF-α. J Immunol, 1991 ; 147 : 4398-401.
5. BEVILACQUA MP, NELSON RM, MANNORI G, CECCONI O. Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med, 1994 ; 45 : 361-78.
6. BLANN AD, MACCOLLUM CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost, 1994 ; 72 : 151-4.
7. BLANN AD, SEIGNEUR M, STEINER M, MILLER JP, MAC COLLUM CN. Circulation ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia : relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemost, 1998 ; 79 : 1080-5.
8. BOLDT J, MULLER M, KHUN D, LINKE LC, HEMPELMANN G. Circulating adhesion molecules in the critically ill : a comparison between trauma and sepsis patients. Intensive Care Med, 1996 ; 22 : 122-8.
9. BROWN E. Neutrophil adhesion and the therapy of inflammation. Semin Hematol, 1997 ; 34 : 319-26.
10. BUDNIK A, GREWE M, GYUFKO K, KRUTMANN J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol, 1996 ; 24 : 352-9.
11. CAMPBELL A, CHANAL I, CZARLEWSKI W, MICHEL FB, BOUSQUET J. Reduction of soluble ICAM-1 levels in nasal secretion by H1-blockers in seasonal allergic rhinitis. Allergy, 1997 ; 52 : 1022-5.
12. CONSTANS J, SEIGNEUR M, BLAN A, RENARD M, RESPLANDY F, AMIRAL J, GUERIN V, BOISSEAU MR, CONRI C. Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction. Thromb Haemost, 1998 ; 80 : 1015-7.
13. COWLEY HC, HENEY D, GEARING A, HEMINGWAY I, WEBSTER NR. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome : a prospective cohort study. Crit Care Med, 1994 ; 22 : 651-7.
14. DIAMOND MS, STAUNTON DE, SPRINGER TA. Binding of the integrin MAC-1 (CD11b/CD18) to the third immunoglobulin like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell, 1991 ; 65 : 961.
15. ENDO S, INADA K, KASAI T, TAKAKUWA T, YAMADA Y, KOIKE S, WAKABAYASHI G, NIIMI M, TANIGUCHI S, YOSHIDA M. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. Inflammation, 1996 ; 46 : 212-9.
16. FASCHING P, VEITL M, ROHAC M, STRELI C, SCHNEIDER B, WALDHAUSL W, WAGNER OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1996 ; 81 : 4313-7.
17. FASSBENDER K, MOSSNER R, MOTSCH L, KISCHKA U, GRAU A, HENNERICI M. Circulating selectin and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke, 1995 ; 26 : 1361-4.
18. GABAZZA EC, KOBAYASHI T, YOSHIDA M, YASUI H, KOBAYASHI H. Circulating intercellular adhesion molecule-1 in patients with lung cancer. Internal Medicine, 1997 ; 36 : 14-8.
19. GEARING AJ, HEMINGWAY I, PIGOTT R, HUGHES J, REES AJ, CASHMAN SJ. Soluble forms of vascular adhesion molecules, E-Selectin, ICAM-1. and VCAM-1 : pathological significance. Ann N Y Acad Sci, 1992 ; 667 : 324-31.
20. GEARING AJ, NEWMAN W. Circulating adhesion molecules in disease. Immunol Today, 1993 ; 14 : 506-12.
21. GHAISAS NK, CHANDRESHWAR NS, FOLEY B, GOGGINS M, CREAN P, KELLY A, KELLEHER D, WALSH M. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol, 1997 ; 80 : 617-9.
22. GLYNN P, COAKLEY R, KILGALLEN I, O'NEILL S. Neutrophil CD11b and soluble ICAM-1 and E-selectin in community acquired pneumonia. Eur Respir J, 1999 ; 13 : 1380-5.
23. GREVE JM, FORTE CP, MARLOR CW, MEYER AM, HOOVER-LITTY H, WUNDERLICH D, MCCLELLAND A. Mechanism of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1. J Virol, 1991 ; 65 : 6015-23.
24. HACKMAN A, ABE Y, INSULL W, POWNALL H, SMITH L, DUNN K, GOTTO AM, BALLANTYNE CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation, 1996 ; 93 : 1334-8.
25. HARLAN JM. Leucocyte-endothelial interactions. Blood, 1985 ; 65 : 513-25.
26. HASHIMOTO M, SHINGU M, EZAKI I, NOBUNAGA M, MINAMIHARA M, KATO K, SUMIOKI H. Production of soluble ICAM-1 from human endothelial cells induced by IL-1β and TNF-α. Inflammation, 1994 ; 18 : 163-73.
27. HATZISTILIANOU M, ATHANASSIADOU F, AGGURIDAKI C. Circulating soluble adhesion molecules levels in children with acute lymphoblastic leukemia. Eur J Pediatr, 1997 ; 156 : 537-40.
28. JONES SC, BANKS RE, HAIDAR A, GEARING AJ, HEMINGWAY IK, IBBOTSON SH, DIXON MF, AXON AT. Adhesion molecules in inflammatory bowel disease. Gut, 1995 ; 36 : 724-30.
29. KAIKITA K, OGAWA H, YASUE H, SAKAMOTO T, MIYAO Y, SUEFUJI H, SOEJIMA H, TAYAMA S, HAYASAKI K, HONDA T, KAMIJIKKOKU S. Increased plasma soluble intercellular adhesion molecule-1 levels in patients with acute myocardial infarction. Jpn Circ J, 1997 ; 61 : 741-8.
30. KANAGAWA K, SEKI Y, NISHIGAKI F, TAKEUCHI K, TANDA K, NONOMURA T, CHIKARAISHI T, TOGASHI M, HIRANO T, KOYANAGI T. Measurement of soluble ICAM-1 after renal transplantation. Transplantation proceedings, 1994 ; 26 : 2103-5.
31. KAUFMANN P, TILZ GP, SMOLLE KH, DEMEL U, KREJS GJ. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (c ICAM-1) in patients with necrotizing pancreatitis. Immunobiology, 1996 ; 195 : 209-19.
32. KIGUCHI T, TAKAHASHI K, UWABE Y, NAKAMURA H. Subthreshold hyperoxia potentiates TNF-alpha-induced ICAM-1 expression on cultured pulmonary microvascular endothelial cells. Exp Lung Res, 1997 ; 23 : 191-204.
33. KOIDE M, FURUKAWA F, TOKURA Y, SHIRAMA S, TAKIGAWA M. Elevation of soluble cell adhesion molecules in atopic dermatitis. J Dermatol, 1997 ; 24 : 88-93.
34. KURYLISZYN-MOSKAL A, BERNACKA K, KLIMIUK PA. Circulating intercellular adhesion molecule-1 in rheumatoïd arthritis-relationship to systemic vasculitis and microvascular injury in naifold capillary microscopy. Clin Rheumatol, 1996 ; 15 : 367-73.
35. KURZ RW, GRAF B, GREMMEL F, WURNIG C, STOCKENHUBER F. Increased serum concentrations of adhesion molecules after coronary angioplasty. Clin Sci, 1994 ; 87 : 627-33.
36. LEDEBUR HC, PARKS TP. Transcriptional regulation of intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem, 1995 ; 270 : 933-43.
37. LEEUWENBERG JFM, SMEETS EF, NEEFJES JJ, SHAFFER MA, CINEK T, JEUNHOMME TM, AHERN TJ, BUURMAN WA. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 1992 ; 77 : 543-9.
38. LEJOLY-BOISSEAU H, BLANN A, SEIGNEUR M, TRIBOULEY-DURET J, TRIBOULEY J, BOISSEAU MR. Endothelium activation related increase of soluble intercellular molecule-1 in human schistosomiasis. Lack of correlation with serology. Eur J Clin Invest, 1996 ; 26 : 522-3.
39. LI YH, TENG JK, TSAI WC, TSAI LM, LIN LJ, CHEN JH. Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction. Am J Cardiol, 1997 ; 80 : 1218-21.
40. LIM AG, WOLFHAGEN HJ, VERMA A, VAN BUUREN HR, JAZRAWI RP, LEVY JH, NORTHFIELD TC, SCHALM SW. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis : effect of ursodeoxycholic acid and immunosuppressive therapy. Eur J Gastroent Hepat, 1997 ; 9 : 155-61.
41. MARLIN SD, STAUNTON DE, SPRINGER TA, STRATOWA C, SOMMERGRUBER W, MERLUZZI VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature, 1990 ; 344 : 70-2.
42. MC GUIRE W, HILL AV, GREENWOOD BM, KIATKOWSKI D. Circulating ICAM-1 levels in falciparum malria are high but unrelated to disease activity. Transaction of the Royal Society of Tropical Medicine & Hygiene, 1996 ; 90 : 274-6.
43. MELICONI R, PULSATELLI L, MECCHIORI C, FRIZZIERO L, SALVARANI C, MACCHIONI P, UGOCCIONI M, FOCCHERINI MC, FACCHINI A. Synovial expression of cell adhesion molecules in polymialgia rheumatica. Clin Exp Immnunol, 1997 ; 107 : 494-500.
44. MEYER DM, DUSTIN ML, CARRON CP. Characterization of Intercellular Adhesion Molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol, 1995 ; 155 : 3578-84.
45. MORANDINI R, GHANEM G, PORTIER-LEMARIÉ A, ROBAYE B, RENAUD A, BOEYNAEMS JM. Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol, 1996 ; 270 : H807-H816.
46. MUSOLINO C, ALONCI A, ALLEGRA A, BELLOMO G, SPATARI G, PERNICE F, SQUADRITO G, QUARTARONE C, TRINGALI O, QUARTARONE M. Circulating levels of intercellular adhesion molecule-1 and soluble interleukin-2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukemia. Rivista Europea per le Scienze Mediche e Farmacologiche, 1996 ; 18 : 113-8.
47. NASU K, NARAHARA H, ETOH Y, KANANO Y, HIROTA Y, MIYAKAWA I. Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and the expression of ICAM-1 mRNA in uterine cervical cancer. Gynecol Oncol, 1997 ; 65 : 304-8.
48. OHLIN A, HOOVER-LITTY H, SANDERSON G, PAESSENS A, JOHNSTON SL, HOLGATE ST, HUGUENEL E, GREVE JM. Spectrum of activity of soluble intercellular molecule 1 against rhinovirus reference strains and field isolates. Antimicrobial agents and chemotherapy, 1994 ; 386 : 1413-5.
49. OHNO N, ICHIKAWA H, COE L, KVIETYS PR, GRANGER DN, ALEXANDER JS. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 1997 ; 21 : 313-24.
50. OLSON JA, WHITELAW CM, MCHARDY KC, PEARSON DWM, FORRESTER JV. Soluble leukocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diaberologia, 1997 ; 40 : 1166-71.
51. PARTRICK DA, MOORE FA, MOORE EE, BIFFL WL, SAUAIA A, BARNETT CC JR. The inflammatory profile of interleukin-6, interleukin-8, and soluble adhesion molecule-1 in postinjury multiple organe failure. Am J Surg, 1996 ; 172 : 425-31.
52. PIGOTT R, DILLON LP, HEMINGWAY IH, GEARING AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Comm, 1992, 187 : 584-9.
53. QI J, KREUTZER DL, PIELA-SMITH TH. Fibrin induction of ICAM-1 expression on human vascular endothelial cells. J Immunol, 1997 ; 158 : 1880-6.
54. RICHARD S, SEIGNEUR M, BLANN A, ADAMS R, RENARD M, PUNTOUS M, BOIRON JM, AMIRAL J, REIFFERS J, BOISSEAU MR. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant, 1996 ; 18 : 955-9.
55. RIECKMANN P, MICHEL U, ALBRECHT M, BRÜCK W, WÖKEL L, FELGENHAUER K. Cerebral endothelial cells are a major source for soluble intercellular adhesion molecule-1 in the human central nervous system. Neuroscience Letters, 1995 ; 186 : 61-4.
56. RIECKMANN P, MICHEL V, ALBRECHT M, BRUCK W, WOCKEL L, FELGENHAUER K. Soluble forms of ICAM-1 block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol, 1995 ; 60 : 9-15.
57. ROKHLIN OW, COHEN MB. Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Lett, 1996 ; 107 : 29-35.
58. ROSS L, DAVIS CM, MOLONY L. A truncated recombinant ICAM-1 inhibits adhesion of leukemic cell lines to upregulated endothelial cells. In Vitro Cell Dev Boil Anim, 1994 ; 30A : 875-80.
59. ROTHLEIN A, MAINOLFI EA, CZAJKOWSKI M, MARLIN SD. A form of circulating ICAM-1 in human serum. J Immunol, 1991 ; 147 : 3788-93.
60. SALMAGGI A, EOLI M, FRIGERIO S, CUSANI E, SILVANI A, BOIARDI A. Cancer Lett, 1999 ; 146 : 169-72.
61. SAMPOL J, GEORGE F. Mesure de paramètres biologiques d'origine endothéliale : intérêt en pathologie humaine. Ann Biol Clin, 1995 ; 53 : 329-38.
62. SANO Y, HIRAI S, KATAYAMA M, KATO I. Immunoenzymometric analysis for expression and shedding of intercellular adhesion molecule-1 on human endothelial cells stimulated with cytokines or lipopolysaccharide. Mol Cell Biochem, 1994 ; 139 : 123-30.
63. SCARABIN PY, ALHENC-GELAS M, OGER E, PLU-BUREAU G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women. Thromb Haemost, 1990 ; 81 : 673-5.
64. SCHADENDORF D, DIEHL S, ZUBERBIER T, SCHADENDORF C, HENZ BM. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology, 1996, 192 : 89-93.
65. SCHAIDER H, RECH-WEICHSELBRAUN I, RICHTIG E, SEIDL H, SOYER HP, SMOLLE J, KERL H. Circulating adhesion molecules as prognostic factors for cutaneous melanoma. J Am Acad Dermatol, 1997 ; 36 : 209-13.
66. SCOTTO-GOMEZ E, SEIGNEUR M, RENARD M, BARTHE C, GADOT A, BOISSEAU MR. Etude de la secrétion d'ICAM-1 soluble dans le surnageant de culture de cellules endothéliales. Réunion GEHT, Marseille, Octobre 1998 (abstract p. 68).
67. SEIGNEUR M, CONSTANS J, BLANN A, RENARD M, PELLEGRIN JL, AMIRAL J, BOISSEAU MR, CONRI C. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost, 1997 ; 77 : 646-9.
68. SESSLER CN, WINDSOR AC, SCHWARTZ M, WATSON L, FISHER BJ, SUGERMAN HJ, FOWLER AA. Circulating ICAM-1 is increased in septic shock. Am J Resp Crit Care Med, 1995 ; 151 : 1420-7.
69. SETH R, RAYMOND FD, MAKGOBA MW. Circulating ICAM-1 isoforms : diagnostic prospects for inflammatory and immune disorders. Lancet, 1991 ; 338 : 83-4.
70. SHINGU M, HASHIMOTO M, EZAKI I, NOBUNAGA M. Effect of cytokine-induced soluble ICAM-1 from human synovial cells on synovial cell-lymphocyte adhesion. Clin Exp Immunol, 1994 ; 98 : 46-51.
71. SHYU KG, CHANG H, LIN CC. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol, 1997 ; 244 : 90-3.
72. SIMINIAK T, DYE JF, EGDELL RM, MORE R, WYSOCKI H, SHERIDAN DJ. The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty. Int J Cardiol, 1997 ; 61 : 113-8.
73. SOYLEMEZOGLU O, SULTAN N, GURSEL T, BUYAN N, HASANOGLU E. Circulating adhesion molecules ICAM-1, E-selectin. and von Willebrand factor in Henoch-Schonlein purpura. Arch Dis Child, 1996 ; 75 : 507-11.
74. SQUADRITO F, SAITTA A, ALTAVILLA D, IOCULANO M, CANALE P, CAMPO GM, SQUADRITO G, DI TANO G, MAZZU A, CAPUTI AP. Thrombolytic therapy with urokinase reduces increased circulating endothelial adhesion molecules in acute myocardial infarction. Inflamm Res, 1996 ; 45 : 14-9.
75. STAUNTON DE, DUSTIN ML, ERICKSON HP, SPRINGER TA. The arrangement of the immunoglobulin like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell, 1990 ; 61 : 243.
76. STAUNTON DE, MARLIN SD, STRATOWA C, DUSTIN ML, SPRINGER TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell, 1988 ; 52 : 925-33.
77. SZEKANECZ Z, SHAH MR, PEARCE WH, KOCH AE. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells : a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Am Exp Immunol, 1994 ; 98 : 337-43.
78. TULEK N, AYDINTUG O, OZORAN K, TUTKAK H, DUZGUN N, DUMAN M, TOKGOZ G. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clin Rheumatol, 1996 ; 15 : 47-50.
79. VANHEE D, MOLET S, GOSSET P, TILLIE-LEBLOND I. BOITELLE A, WALLAERT B, TONNEL AB. Expression of leucocyte-endothelial adhesion molecules is limited to intercellular adhesion molecule-1 (ICAM-1) in the lung of pneumoconiotic patients : role of tumour necrosis factor-alpha (TNF-alpha). Clin Exp Immunol, 1996 ; 106 : 541-8.
80. WAHL SM, FELDMAN GM, MC CARTHY JB. Regulation of leukocyte adhesion and signaling in inflammation and disease. J Leukocyte Biol, 1996 ; 59 : 1789-96.
81. WENISH C, MYSKIW D, PARSCHALK B, HARTMANN T, DAM K, GRANINGER W. Soluble endothelium-associated adhesion molecules in patients with Graves'disease. Clin Exp Immunol, 1994 ; 98 : 240-4.